Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Avacta Life Sciences Ltd
Jonsson Comprehensive Cancer Center
University Health Network, Toronto
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center